Exact Mass: 271.1531986

Exact Mass Matches: 271.1531986

Found 88 metabolites which its exact mass value is equals to given mass value 271.1531986, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Napropamide

C17H21NO2 (271.1572206)

CONFIDENCE standard compound; INTERNAL_ID 66; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9402; ORIGINAL_PRECURSOR_SCAN_NO 9401 CONFIDENCE standard compound; INTERNAL_ID 66; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9441; ORIGINAL_PRECURSOR_SCAN_NO 9439 CONFIDENCE standard compound; INTERNAL_ID 66; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9439; ORIGINAL_PRECURSOR_SCAN_NO 9438 CONFIDENCE standard compound; INTERNAL_ID 66; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9388; ORIGINAL_PRECURSOR_SCAN_NO 9387 CONFIDENCE standard compound; INTERNAL_ID 66; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9460; ORIGINAL_PRECURSOR_SCAN_NO 9459 CONFIDENCE standard compound; INTERNAL_ID 66; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9346; ORIGINAL_PRECURSOR_SCAN_NO 9345 INTERNAL_ID 3573; CONFIDENCE standard compound CONFIDENCE standard compound; INTERNAL_ID 3573

Apoatropine

BENZENEACETIC ACID, .ALPHA.-METHYLENE-, (3-ENDO)-8-METHYL-8-AZABICYCLO(3.2.1)OCT-3-YL ESTER

C17H21NO2 (271.1572206)

METHOPROTRYNE

C11H21N5OS (271.14667360000004)

4-Hydroxyatomoxetine

3-methyl-4-[(1R)-3-(methylamino)-1-phenylpropoxy]phenol

C17H21NO2 (271.1572206)

4-Hydroxyatomoxetine is a metabolite of atomoxetine. Atomoxetine is a drug approved for the treatment of attention-deficit hyperactivity disorder (ADHD). It is a selective norepinephrine reuptake inhibitor or NRI, not to be confused with selective serotonin and norepinephrine reuptake inhibitors or selective serotonin reuptake inhibitors, both of which are currently the most prescribed form of antidepressants. (Wikipedia)

Desomorphine

4-methyl-12-oxa-4-azapentacyclo[9.6.1.0¹,¹³.0⁵,¹⁷.0⁷,¹⁸]octadeca-7(18),8,10-trien-10-ol

C17H21NO2 (271.1572206)

Nisoxetine

DL-N-Methyl-3-(O-methoxyphenoxy)-N-methyl-3-phenylpropylamine

C17H21NO2 (271.1572206)

C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C185721 - Norepinephrine Reuptake Inhibitor C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent

Cocculine

16-methoxy-10-azatetracyclo[8.7.0.0¹,¹³.0²,⁷]heptadeca-2(7),3,5,13-tetraen-4-ol

C17H21NO2 (271.1572206)

Quinocitrinine A

(+)-2,3-Dihydro-6-hydroxy-4-methyl-3-(1-methylpropyl)-1-oxo-1H-pyrrolo[3,4-b]quinolinium

C16H19N2O2 (271.1446454)

Quinocitrinine B

(-)-2,3-Dihydro-6-hydroxy-4-methyl-3-(1-methylpropyl)-1-oxo-1H-pyrrolo[3,4-b]quinolinium

C16H19N2O2 (271.1446454)

Permonid

C17H21NO2 (271.1572206)

1-(Cyclohexylmethyl)-1H-indole-3-carboxylic Acid Methyl Ester

C17H21NO2 (271.1572206)

wallemia A

C17H21NO2 (271.1572206)

O-methyldehydrojourbertiamine

C17H21NO2 (271.1572206)

ACMC-20lir5

C12H21N3O4 (271.1531986)

2-((S)-3-Methyl-2-((S)-pyrrolidine-2-carboxamido)butanamido)acetic acid

C12H21N3O4 (271.1531986)

Val Pro Gly

C12H21N3O4 (271.1531986)

Pro Gly Val

C12H21N3O4 (271.1531986)

Napropamid

Napropamide

C17H21NO2 (271.1572206)

CONFIDENCE standard compound; EAWAG_UCHEM_ID 120

heptylphenazolone

C17H21NO2 (271.1572206)

Benzyl homoveratrylamine

C17H21NO2 (271.1572206)

1,N6-4-Oxo-(2E)-nonenal-adenine

C14H17N5O1 (271.1433032)

Pesticide5_Methoprotryne_C11H21N5OS_

C11H21N5OS (271.14667360000004)

Bifemelane (M6)

C17H21NO2 (271.1572206)

Gly Pro Val

C12H21N3O4 (271.1531986)

Pro Val Gly

C12H21N3O4 (271.1531986)

Val Gly Pro

C12H21N3O4 (271.1531986)

Gly Val Pro

C12H21N3O4 (271.1531986)

Desomorphine

C17H21NO2 (271.1572206)

D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D000700 - Analgesics

BIS(2-CYANOETHYL) DIISOPROPYLPHOSPHORAMIDITE

C12H22N3O2P (271.1449562)

Bis(2-cyanoethyl) diisopropylphosphoramidite is a phosphorite monomer that can be used in the synthesis of oligonucleotides.

BENZYL-[1-(3,4-DIMETHOXYPHENYL)ETHYL]AMINE

C17H21NO2 (271.1572206)

4-Cyanophenyl trans-4-propylcyclohexanecarboxylate

C17H21NO2 (271.1572206)

ProcainaMide hydrochloride

C13H22ClN3O (271.1451312)

D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers > D061567 - Voltage-Gated Sodium Channel Blockers C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker

(S)-1-(benzylamino)-3-(benzyloxy)propan-2-ol

C17H21NO2 (271.1572206)

n,n-dimethylformamide dibenzyl acetal

C17H21NO2 (271.1572206)

methyl 2-[[(E)-(2,4-dimethylcyclohex-3-en-1-ylidene)methyl]amino]benzoate

C17H21NO2 (271.1572206)

5-(1H-imidazol-1-yl)pyridine-3-boronic acid pinacol ester

C14H18BN3O2 (271.1491998)

(3,4-DIMETHOXY-BENZYL)-(1-PHENYL-ETHYL)-AMINE

C17H21NO2 (271.1572206)

2-(1H-PYRAZOL-1-YL)-6-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDINE

C14H18BN3O2 (271.1491998)

2,4-ivy carbaldehyde / methyl anthranilate schiffs base

C17H21NO2 (271.1572206)

2-[4-(Benzyloxy)-3-ethoxyphenyl]ethanamine

C17H21NO2 (271.1572206)

benzyl-[2-(3-methoxyanilino)-2-oxoethyl]azanium

C16H19N2O2+ (271.1446454)

Furan-2-ylmethyl-[1-(4-methoxy-phenyl)-3-methyl-but-3-enyl]-amine

C17H21NO2 (271.1572206)

(2,3-DICHLOROPHENYL)METHYLCYANOCARBONIMIDODITHIOATE

C17H21NO2 (271.1572206)

2-Heptyl-1,4-dihydro-4-oxo-3-quinolinecarboxaldehyde

C17H21NO2 (271.1572206)

BENZYL-[2-(3,4-DIMETHOXY-PHENYL)-ETHYL]-AMINE

C17H21NO2 (271.1572206)

N-cyclopentyl-5-(4-fluorophenyl)-2-methylpyrimidin-4-amine

C16H18FN3 (271.14846800000004)

(1S)-N-(3,4-Dimethoxybenzyl)-1-phenylethanamine

C17H21NO2 (271.1572206)

2-(N,N-DIBENZYL)-AMINO-1,3-PROPANEDIOL

C17H21NO2 (271.1572206)

tert-Butyl 4-[(Trimethylsilanyl)oxy]-3,6-dihydro-2H-pyridine-1-carboxylate

C13H25NO3Si (271.160362)

2-(1H-PYRAZOL-1-YL)-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PYRIDINE

C14H18BN3O2 (271.1491998)

(1R)-N-(3,4-Dimethoxybenzyl)-1-phenylethanamine

C17H21NO2 (271.1572206)

Napropamide-M

C17H21NO2 (271.1572206)

(S)-napropamide

C17H21NO2 (271.1572206)

H-Pro-Val-Gly-OH

C12H21N3O4 (271.1531986)

Glycine, L-valyl-L-prolyl-

C12H21N3O4 (271.1531986)

Pro-Gly-Val

C12H21N3O4 (271.1531986)

2-Decenoyl N-acetyl cysteamine

C14H25NO2S (271.160591)

[2-(1-Amino-2-hydroxypropyl)-2-hydroxy-4-isobutyl-5-oxo-2,5-dihydro-1H-imidazol-1-YL]acetaldehyde

C12H21N3O4 (271.1531986)

Nisoxetine

C17H21NO2 (271.1572206)

C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C185721 - Norepinephrine Reuptake Inhibitor C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent

Pronestyl

C13H22ClN3O (271.1451312)

D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers > D061567 - Voltage-Gated Sodium Channel Blockers D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D049990 - Membrane Transport Modulators